[By NBC-1TV H. J Yook]The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced four new university clients—bringing academic institution totals to 30—who have selected Directors Desk, one of the world‘s leading secure board portals, to bolster board communications and effectiveness. Ball State University, Oregon State University, Seton Hall University and Texas Tech University have all inked 12-month renewable contracts with NASDAQ OMX to leverage Directors Desk’s industry leading cloud technology for boards. “Enhancing board communications is a major goal of our strategic plan,” s
[By NBC-1TV H. J Yook]B-Scada (OTCQB: MOBS) has filed its 10Q for the quarter ending April 30, 2013. Our quarterly revenues increased from $197,508 to $440,270, for an increase of $242,762. Additionally, our second quarter net income increased $212,441. “Sales of our existing SCADA products are strengthening,” says Ron DeSerranno, CEO. “Combined with our long term technology licensing agreements, this puts us in a very good position for continued growth. New products to be released towards the end of the year will add even more momentum. It is a very exciting time for our customers, shareholde
[By NBC-1TV H. J Yook]Samsung Electronics Co., Ltd., the world leader in advanced memory technology, announced today that it has begun mass producing the industry’s first PCI-Express (PCIe) solid state drive (SSD) for next-generation ultra-slim notebook PCs. “With the Samsung XP941, we have become the first to provide the highest performance PCIe SSD to global PC makers so that they can launch leading-edge ultra-slim notebook PCs this year,” said Young-Hyun Jun, executive vice president, memory sales & marketing, Samsung Electronics. “Samsung plans to continue timely delivery of the most advan
[By NBC-1TV H. J Yook]Commencing on International Day of the African Child on June 16, LG Electronics and the International Vaccine Institute (IVI), in collaboration with local partners, will launch a public awareness and vaccination campaign to reduce acute watery diarrheal disease (AWD) resulting from cholera infections. The organizations expect to vaccinate more than 20,000 residents in selected districts of West Arsi Zone in Ethiopia’s Oromia Region. LGE has been supporting IVI’s vaccine program in Ethiopia since 2010 to stem the spread of AWD. Together, the organizations conducted vaccine
[By NBC-1TV H. J Yook]Raon Solution Co., Ltd.(CEO Cho, Hwa-ju), a middle-sized enterprise located in the Gumi National industrial Complex, releases ‘Ara’, a dongle-based remote controller to be mounted on a smart phone. The company official said the smart remote could be completed with the support of the cluster project by the Daegyeong Area Headquarter(Head officer Park, Chan-deuk) of the Korea Industrial Complex Corp and added the firm obtained a patent on a smart remote controller based on an earpiece jack. The existing smart remotes were too expensive for many consumers and especially the
[By NBC-1TV H. J Yook]Mayapada Hospital South Jakarta performed its first ever laparoscopic surgery to remove fibroids from a woman's body on Wednesday, June 12th. The successful surgery was performed by a team of medical experts led by Dr. Setyo Hermanto, SpOG. The patient, a woman aged 39, Mrs. Suliyem, came with a complaint of uterine myomas (fibroids). “The patient had fibroids weighing more than two pounds. After conducting a thorough examination and a review of her health record, we and her family decided to remove the fibroids through a Total Laparoscopic Hysterectomy (TLH) surgery. All
[By NBC-1TV H. J Yook]New guidelines released by the Thalassaemia International Federation (TIF) address the Management of Non-Transfusion Dependent Thalassaemias (NTDT) and are a first of their kind in the field of medical haematology. The guidelines, presented today at the 18th Congress of the European Haematology Association (EHA), provide a consensus of international expert opinion based on the latest data in the field, and were developed to give clinicians easy-to-follow protocols to better identify and manage this patient population, who are often overlooked or under-diagnosed. NTDT is a
[NBC-1TV H. J Yook]NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today that its lead compound NBTXR3 has received authorization from the French Medicine Agency, ANSM[1], to start a clinical trial in patients with locally advanced cancers of the oral cavity or oropharynx (head and neck cancer), at the Institut Curie, Paris, France, a French leading cancer treatment center. This represents a second indication for NBTXR3 which is also in clinical trials for soft tissue sarcoma. The phase I trial will be